Quelicin (Hospira, Inc.)
Welcome to the PulseAid listing for the Quelicin drug offered from Hospira, Inc.. This Depolarizing Neuromuscular Blocker [EPC],Neuromuscular Depolarizing Blockade [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | Succinylcholine Chloride |
SUBSTANCE NAME: | SUCCINYLCHOLINE CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Depolarizing Neuromuscular Blocker [EPC],Neuromuscular Depolarizing Blockade [PE] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-04-30 |
END MARKETING DATE: | 0000-00-00 |
Quelicin HUMAN PRESCRIPTION DRUG Details:
Item Description | Quelicin from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2005-04-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-6629_8ae66f81-311d-41c1-9a8b-0d8c27e7ac69 |
PRODUCT NDC: | 0409-6629 |
APPLICATION NUMBER: | NDA008845 |
Other SUCCINYLCHOLINE CHLORIDE Pharmaceutical Manufacturers / Labelers: